Prescription Drugs - Timor-Leste

  • Timor-Leste
  • In Timor-Leste, the revenue in the Prescription Drugs market is forecasted to reach US$8.54m by 2024.
  • It is expected to exhibit an annual growth rate (CAGR 2024-2029) of 3.33%, leading to a market volume of US$10.06m by 2029.
  • When compared globally, United States is projected to generate the highest revenue of US$358.90bn in 2024.
  • Taking into account the total population figures, per person revenues of US$6.19 are anticipated in 2024.
  • The prescription drug market in Timor-Leste is experiencing a surge in demand for essential medicines due to increasing healthcare access.

Key regions: Japan, China, Europe, Australia, Canada

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Prescription Drugs (Pharmacies) market in Timor-Leste is experiencing significant growth and development.

Customer preferences:
Customers in Timor-Leste have shown a growing preference for prescription drugs from pharmacies. This can be attributed to several factors, including the increasing awareness and importance of healthcare, as well as the convenience and accessibility of pharmacies. Customers prefer to obtain their prescription drugs from pharmacies due to the professional advice and guidance provided by pharmacists, ensuring the correct usage and dosage of medications.

Trends in the market:
One of the key trends in the Prescription Drugs (Pharmacies) market in Timor-Leste is the expansion of pharmacy chains. This trend can be observed in the increasing number of pharmacy outlets across the country, catering to the growing demand for prescription drugs. The expansion of pharmacy chains allows for a wider range of medications to be available to customers, ensuring that they have access to the drugs they need. Additionally, pharmacy chains often offer competitive pricing and promotions, making prescription drugs more affordable for customers. Another trend in the market is the increasing availability of generic prescription drugs. Generic drugs are becoming more widely accepted and trusted by customers in Timor-Leste, as they offer similar efficacy and quality as branded drugs but at a lower cost. This trend is driven by the efforts of both local and international pharmaceutical companies to produce and promote generic drugs in the market. The availability of generic drugs provides customers with more options and affordability when it comes to their prescription medications.

Local special circumstances:
Timor-Leste is a developing country with a growing population and an increasing focus on healthcare. The government has been implementing policies and initiatives to improve access to healthcare services, including the provision of prescription drugs. The establishment of the National Medicines and Medical Devices Authority (NMMDA) has also played a crucial role in regulating and ensuring the quality of prescription drugs available in the market. These local special circumstances have created a conducive environment for the growth and development of the Prescription Drugs (Pharmacies) market in Timor-Leste.

Underlying macroeconomic factors:
The growth and development of the Prescription Drugs (Pharmacies) market in Timor-Leste can also be attributed to underlying macroeconomic factors. The country has been experiencing steady economic growth, which has led to an increase in disposable income and improved living standards. As a result, more people are able to afford prescription drugs and are willing to spend on their healthcare needs. Additionally, the government has been investing in healthcare infrastructure and services, further driving the demand for prescription drugs. The combination of these macroeconomic factors has created a favorable market environment for the Prescription Drugs (Pharmacies) industry in Timor-Leste.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)